RNS Number : 8072N BlackRock Group 24 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE…
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose…
RNS Number : 8406N CVC Income & Growth Limited 24 July 2026 24 July 2026CVC Income & Growth LimitedIssue of EquityCVC Income & Growth Limited (the Company) announces that on 24 July 2026, it resold from treasury 250,000 Sterling shares for cash at a price of £1.1992 per Sterling share, to meet…
RNS Number : 8440N British Land Co PLC 24 July 2026 TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB0001367019Issuer NameBRITISH LAND COMPANY PUBLIC LIMITED COMPANY(THE)UK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Deta…
RNS Number : 8438N FIL Limited 24 July 2026 Ap27FORM 8.3IRISH TAKEOVER PANELOPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORM…
RNS Number : 8442N FIL Limited 24 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DIS…
Q1 FY27 saw strong profitability and cash flow despite a 4.2% revenue decline, with national security growth offsetting civil headwinds. Investments in cyber, defense tech, and AI are driving future growth, and the Ultra I&C Mission Solutions acquisition is set to strengthen the defense tech portfo…
RNS Number : 8439N FIL Limited 24 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DIS…
RNS Number : 8436N FIL Limited 24 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DIS…
RNS Number : 8435N Trium Capital LLP 24 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING T…
RNS Number : 8437N JPMorgan Asset Management 24 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% ORMORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLO…
RNS Number : 8434N JPMorgan Asset Management 24 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% ORMORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLO…
The Board of Directors of OncoZenge AB (publ) (“OncoZenge” or “the Company”) has resolved to extend the payment deadline for payment of the remaining subscription proceeds of approximately SEK 10.1 million in the directed share issue to Sichuan Yangtian Bio-Pharmaceutical Co, Ltd (the “Investor”…
– Whole-gland TULSA ablation demonstrates statistically significant superior penile length preservation compared to robotic RP at 1 month –TORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device compan…
United Bancorp reported second-quarter 2026 net income of $2,094,738 and diluted earnings per share of $0.36, up 9.4% and 9.1% year-over-year respectively. For the six months ended June 30, 2026, net income was $4,005,555 and diluted EPS was $0.69, increases of 5.8% and 6.2% year-over-year. The com…
Provident appointed Donavon P. Ternes to the Boards of Directors and named Michael S. Van Stockum Senior Vice President and Chief Lending Officer, both effective July 23, 2026.Original SEC Filing: PROVIDENT FINANCIAL HOLDINGS INC [ PROV ] - 8-K - Jul. 24, 2026This is an AI-powered summary. It may c…
Q2 2026 delivered strong loan and deposit growth, improved asset quality, and higher net income. Margins remained stable despite deposit pricing pressures, and efficiency ratios stayed below 60%. Management expects continued growth and stable expenses for the remainder of the year.Based on First Ba…
Record Q2 sales and revenue were driven by strong electrified vehicle growth and market share gains, despite global demand headwinds. Operating profit declined YoY due to higher incentives and FX impacts, but net profit rose and H2 guidance remains robust.Based on Kia Corporation [000270] Q2 2026 A…
Toronto, Ontario--(Newsfile Corp. - July 24, 2026) - Brompton Funds TSX:DGS TSX:ESP TSX:GDV TSX:LBS TSX:LCS (TSX: LCS.PR.A) TSX:PWI TSX:SBC announces distributions payable on August 11, 2026 to class A shareholders of record at the close of business on July 31, 2026 for each of the following funds…
RNS Number : 8432N Trium Capital LLP 24 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING T…
